Dr. Emilio Denicio Sulpizio, MD

  • Spokane, WA
  • Hematologist and oncologist
NPI1730543117PAC ID3274829569
Medicare services, 2024
600
Medicare patients, 2024
222
Part D claims, 2024
1,181
Publications
3
Hospital affiliations
3
Practice address
800 W 5th Ave, Spokane, WA 99204
Practice phone
Call (509) 473-7178
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Multicare Deaconess Hospital

Spokane, Washington

See all 5 affiliations

Find Dr. Sulpizio's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Emilio Denicio Sulpizio is a hematologist and oncologist in Spokane, Washington

Dr. Sulpizio practices at Multicare Deaconess Hospital in Spokane, Washington.

Dr. Sulpizio's NPI, 1730543117, was assigned on April 11, 2016. Dr. Sulpizio graduated from University of Washington School of Medicine in 2016. Dr. Sulpizio holds Washington license MD61271235.

NPI and contact details
Medicare PAC ID
3274829569
NPI enumeration date
April 11, 2016
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(509) 473-7178
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
36
Medical school graduation
2016

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Emilio Denicio Sulpizio practices at Multicare Deaconess Hospital in Spokane, Washington

Dr. Sulpizio's primary practice is Multicare Deaconess Hospital, at 800 W 5th Ave, Spokane, WA 99204 in Spokane County. The practice phone is (509) 473-7178.

  • Multicare Deaconess Hospital
    800 W 5th Ave, Spokane, WA 99204 · Spokane CountyPhone(509) 473-7178

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Emilio Denicio Sulpizio is affiliated with 4 sites of care and 1 medical group

Dr. Sulpizio's primary practice is Multicare Deaconess Hospital in Spokane, Washington. Dr. Sulpizio is also affiliated with MultiCare Deaconess Hospital. The medical group on file is MultiCare Indigo Urgent Care, Spokane, Newport Hwy. Dmand AI also links Dr. Sulpizio to 2 more hospitals, each named with a free account.

See all 5 affiliations for Dr. Sulpizio

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Emilio Denicio Sulpizio's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sulpizio practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Multicare Deaconess HospitalAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Sulpizio practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Emilio Denicio Sulpizio is one of 348 hematologists and oncologists in Washington

Hematology and oncology is Dr. Sulpizio's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Sulpizio's licenses on file in 3 states: Washington, California and Oregon.

Specialties and state licenses

  • Hematology and oncology, WashingtonPrimaryLicense MD61271235 · taxonomy 207RH0003X
  • Hospitalist, CaliforniaLicense A162146 · taxonomy 208M00000X
  • Internal medicine, OregonLicense MD191745 · taxonomy 207R00000X

Hematologists and oncologists near Dr. Sulpizio

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

348hematologists and oncologists in Washington
9hematologists and oncologists in Spokane

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Emilio Denicio Sulpizio billed Medicare for 600 services in 2024

CMS data shows 600 Medicare services from Dr. Sulpizio across 4 procedure codes in 2024, for 222 Medicare patients. Medicare paid $49,064 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024600
Medicare patients222
Paid by Medicare$49,064
Procedure codes4

Dr. Sulpizio's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 6062024: 6001%
Imaging
2023: 122024: 0100%
Other services
2023: 1,3802024: 0100%

Dr. Sulpizio compared with the Washington median for hematologists and oncologists, 2024

  • Dr. Sulpizio
  • Washington median
Medicare services
600vs 585Close to median
Medicare patients
222vs 18222% above
Part D claims
883vs 2833.1 times

Medians across 310 hematologists and oncologists in Washington with Dmand AI profiles that report each measure.

Dr. Sulpizio's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Sulpizio

Need commercial claims for Dr. Sulpizio?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Sulpizio and other hematologists and oncologists in Washington.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Emilio Denicio Sulpizio treated 222 Medicare patients in 2024, average age 76

CMS counts 222 Medicare patients who saw Dr. Sulpizio in 2024. The largest group is 75 to 84, with 94 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sulpizio's median patient age at 74, with 51% women.

Medicare patients, 2024222
Average age76
Average risk score2.40
Also on Medicaid8%

Dr. Sulpizio's Medicare patients by age, 2024

Dr. Sulpizio's Medicare patients by sex, 2024

  • Women10748%
  • Men11552%

Chronic conditions among Dr. Sulpizio's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol69%
  3. Arthritis48%
  4. Cancer47%
  5. Chronic kidney disease38%
  6. Mood disorders30%
  7. Diabetes29%
  8. Depression28%

Share of Medicare patients with each condition. A patient can have several.

Dr. Sulpizio's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 74

Patient panel by sex, all payers

  • Women51%
  • Men49%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Emilio Denicio Sulpizio wrote 1,181 Medicare Part D claims in 2024

In 2024, Dr. Sulpizio wrote 1,181 Medicare Part D claims for 169 patients. 79% of them were for generic drugs. CMS names the drug for 883 of them, across 30 drugs with 11 or more claims each, at $1,953,914 in total drug cost. In 2023, CMS named 469 claims across 18 drugs.

Part D claims, 20241,181
Drugs named by CMS30
Total drug cost$2M
Part D patients169

Dr. Sulpizio's Part D claims by kind of drug, 2024

  • Generic932 claims79%
  • Brand-name and other249 claims21%

Dr. Sulpizio's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Sulpizio's Part D claims, 2024

  • Opioids9%104 of 1,181 claims
  • Antibiotics3%38 of 1,181 claims
  • Antipsychotics, patients 65 and over1%11 of 1,181 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4692024: 88388%

Drugs named by CMS: 30 in 2024, 18 in 2023.

See all prescribing by Dr. Sulpizio

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Emilio Denicio Sulpizio offers telehealth to Medicare patients

Dr. Sulpizio accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sulpizio as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Sulpizio by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Emilio Denicio Sulpizio has 3 publications on record

Dmand AI links 3 papers to Dr. Sulpizio, published from 2018 to 2022. Dr. Sulpizio's most frequent co-authors are Thomas Grier Deloughery, MD, Sven Olson, MD and Vikram Raghunathan, MD.

Papers3
Years published2018 to 2022

Dr. Sulpizio's papers by year, 2018 to 2022

Dr. Sulpizio's most frequent co-authors

Recent publications by Dr. Sulpizio

See all 3 publications and co-authors

See who Dr. Sulpizio researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sulpizio works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Emilio Denicio Sulpizio received $2,196 in industry payments from 2019 to 2023

CMS Open Payments shows 106 general payments to Dr. Sulpizio from 38 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 90% of the total. Novartis Pharmaceuticals Corporation paid the most, $263.

General payments to Dr. Sulpizio by program year, 2019 to 2023

General payments to Dr. Sulpizio by kind, 2019 to 2023

$2.2Kin total
  • Food and beverage$1,98690%
  • Education$21010%

Companies that paid Dr. Sulpizio the most, 2019 to 2023

Share is of all general payments to this clinician.

See all payments to Dr. Sulpizio

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Emilio Denicio Sulpizio graduated from University of Washington School of Medicine

Dr. Sulpizio graduated from University of Washington School of Medicine in 2016.

  1. Medical schoolUniversity of Washington School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Emilio Denicio Sulpizio's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Emilio Denicio Sulpizio

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Emilio Denicio Sulpizio's NPI number?

Dr. Emilio Denicio Sulpizio's NPI number is 1730543117. It was assigned on April 11, 2016, and it is active in the NPI Registry.

What kind of doctor is Dr. Emilio Denicio Sulpizio?

Dr. Emilio Denicio Sulpizio is a hematologist and oncologist in Spokane, Washington. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Emilio Denicio Sulpizio practice?

Dr. Sulpizio practices at 800 W 5th Ave, Spokane, WA 99204. Dr. Sulpizio's primary practice is Multicare Deaconess Hospital in Spokane, Washington. Dmand AI also links Dr. Sulpizio to 2 hospitals.

What is Dr. Emilio Denicio Sulpizio's office phone number?

The practice phone on file for Dr. Sulpizio is (509) 473-7178.

What is Dr. Emilio Denicio Sulpizio's medical license number?

Dr. Sulpizio holds Washington license MD61271235, one of the licenses on file in 3 states.

Which states has Dr. Emilio Denicio Sulpizio been licensed in?

Dmand AI has state licenses on file for Dr. Sulpizio in Washington, California and Oregon.

Which hospitals is Dr. Emilio Denicio Sulpizio affiliated with?

Dr. Sulpizio is affiliated with MultiCare Deaconess Hospital. Dmand AI links Dr. Sulpizio to 2 more hospitals.

What medical group is Dr. Emilio Denicio Sulpizio part of?

Dr. Sulpizio is linked to MultiCare Indigo Urgent Care, Spokane, Newport Hwy.

Does Dr. Emilio Denicio Sulpizio accept Medicare?

Yes. CMS data shows Dr. Sulpizio billed Medicare for 600 services in 2024, and Dr. Sulpizio accepts Medicare assignment.

Does Dr. Emilio Denicio Sulpizio offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Sulpizio as offering telehealth services.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Emilio Denicio Sulpizio see?

CMS counts 222 Medicare patients who saw Dr. Sulpizio in 2024, with an average age of 76.

What services does Dr. Emilio Denicio Sulpizio bill to Medicare?

In 2024, Dr. Sulpizio's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and hospital inpatient care (99233).

Where did Dr. Emilio Denicio Sulpizio go to medical school?

Dr. Sulpizio graduated from University of Washington School of Medicine in 2016.

What drugs does Dr. Emilio Denicio Sulpizio prescribe most?

In 2024 Medicare Part D data, Dr. Sulpizio's most prescribed drugs by claims were Anastrozole, Eliquis and Dexamethasone.

Has Dr. Emilio Denicio Sulpizio received payments from drug or device companies?

CMS Open Payments shows $2,196 in general payments to Dr. Sulpizio from 38 companies from 2019 to 2023. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Emilio Denicio Sulpizio been practicing?

Dr. Sulpizio graduated from medical school in 2016, 10 years ago.

Does Dr. Emilio Denicio Sulpizio do research?

Dmand AI links 3 publications to Dr. Sulpizio, published from 2018 to 2022.

Who does Dr. Emilio Denicio Sulpizio publish with?

Dr. Sulpizio's most frequent co-authors are Thomas Grier Deloughery, MD (2 shared papers), Sven Olson, MD (1 shared paper) and Vikram Raghunathan, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Washington by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)